Entrepreneurs that move from research to clinical development phases and beyond go into a very regulated area with options as well as pitfalls. Chances of success are increased significantly if a company is aware of all this and more good medicines will reach the patients that way.
Ozack wants to increase progress by infusing our knowledge to navigate the regulatory maze through development of medicine within all phases of drug development. We will
• work out regulatory strategies with the company to choose the best route and mitigate risk
• glue clinical, nonclinical, and CMC data together into a well understood story
• ensure successful liaising with Health Authorities as partners rather than opponents
Company Details
- Employees
- 8
- Founded
- -
- Address
- Nordre Fasanvej 215, Frederiksberg,capital Region Of Denmark 2000,denmark
- Industry
- Business Consulting And Services
- NAICS
-
Management, Scientific, and Technical Consulting ServicesManagement Consulting ServicesOther Scientific and Technical Consulting ServicesOther Management Consulting Services
- Website
- ozack.dk
- Keywords
- Global Regulatory Affairs, Leadership, Drug Development, Biotechnology, OZ Principle, Accountability, Project Management.
- HQ
- Frederiksberg, Capital Region of Denmark
Ozack Aps Questions
Ozack Aps's website is ozack.dk
Ozack Aps's LinkedIn profile is https://dk.linkedin.com/company/ozack-aps
Ozack Aps has
8 employees.
View email and phone details for 8
employees at Ozack Aps.
Ozack Aps's industry is
Business Consulting and Services
Ozack Aps's top competitors are
Efi Global (Danmark),
Ascendis Pharma,
Novo Nordisk,
Studynova,
Red Thread Consulting Limited,
Ferring Pharmaceuticals,
Bavarian Nordic,
Leo Pharma,
Fujifilm Biotechnologies,
Lif - Lægemiddelindustriforeningen.
Ozack Aps's categories are Business Consulting and Services
Ozack Aps's founding year is 2016
